ICD-10-CM Billable Code

T43.695

Adverse effect of other psychostimulants

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code T43.695 refers to adverse effects caused by other psychostimulant medications. Psychostimulants are drugs that increase activity in the nervous system and are often prescribed for conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. While these medications can be effective for managing symptoms, they may also lead to undesirable side effects. Recognizing these effects is important for ensuring proper management and care. This guide provides an overview of what adverse effects of psychostimulants entail, their common causes, symptoms, diagnostic approaches, and general treatment considerations.

Causes & Symptoms

Clinical Causes: Use of prescription psychostimulant medications for conditions like ADHD, narcolepsy, or weight management. Accidental overdose or misuse of prescribed stimulants. Drug interactions between psychostimulants and other medications or substances. Individual sensitivity or allergic reactions to the medication ingredients. Chronic use leading to tolerance and increased dosage, raising the risk of adverse effects.

Key Symptoms: Increased heart rate (tachycardia) Elevated blood pressure Agitation, restlessness, or anxiety Insomnia or difficulty sleeping Loss of appetite or weight loss Dizziness or feeling faint Nausea or stomach discomfort Headaches Potential for mood changes, including irritability or euphoria In rare cases, signs of psychosis such as hallucinations or paranoia

Diagnostic & Treatment

Diagnosis Path: Diagnosis of adverse effects from psychostimulants involves a comprehensive review of the patient's medical history, medication regimen, and symptom presentation. Healthcare providers may perform physical examinations and order laboratory tests to rule out other causes. Monitoring the timing of symptoms in relation to medication intake can help establish a link. In some cases, a healthcare provider may adjust or discontinue the medication to observe if symptoms improve, aiding in confirming the adverse effect.

Treatment Protocols: Discontinuing or adjusting the dose of the psychostimulant medication under medical supervision. Providing symptomatic relief for side effects—e.g., medications for blood pressure or sleep disturbances. Implementing behavioral strategies to mitigate symptoms such as anxiety or insomnia. Monitoring cardiovascular function if symptoms like increased heart rate or blood pressure occur. Exploring alternative treatment options for the underlying condition if adverse effects persist. Educating patients about potential side effects and encouraging prompt reporting of any concerning symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T43.695 a billable ICD-10 code?
Yes, T43.695 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T43.695?
Clinical documentation must specify the nature of Adverse effect of other psychostimulants and any associated comorbidities for accurate reporting.

Cite this Clinical Reference